Plain-English translation of NCT07271771 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether , a medication that strengthens bones and reduces fracture risk, may also help improve muscle strength and blood sugar control. Researchers believe the medication might affect how your body processes glucose (blood sugar), but they need to study this more carefully in people with type 2 diabetes. You would receive either the medication or a placebo (inactive treatment) to see what effects it has.
While this medication is already used successfully to treat osteoporosis and prevent fractures, some earlier studies suggest it might also improve blood sugar control—but the results have been mixed and limited. This trial aims to get clearer answers about whether this medication can help with muscle strength and insulin sensitivity in women with type 2 diabetes.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the bone-strengthening medication or a placebo injection. The study would involve multiple clinic visits where researchers measure your bone density, muscle strength, and blood sugar control through physical exams and blood tests. The trial would continue for a set period to track whether the medication has any effects on your muscle, strength, and how your body handles blood sugar.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Denmark
Phase
Post-approval monitoring
Sponsor
Aarhus University Hospital
Collaborators
Sponsor: MD, Professor, DMSc, PhD Bente Lomholt Langdahl
Enrollment target
~40 participants
Started
May 2024
Primary completion
March 2027
Age range
40 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anne Sophie Sølling, MD, PhD
Aarhus University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.